NLCRT and ACR Host Webinar Series on New Lung Cancer Screening Guidelines.

Join the American Cancer Society National Lung Cancer Roundtable (NLCRT) for a monthly series, sponsored by AstraZeneca and Genentech, a member of the Roche Group, to narrow the knowledge gaps regarding the new lung cancer screening (LCS) eligibility criteria from the U.S. Preventive Services Task Force (USPSTF). The series begins on June 30, 2021 from 12:00-1:00pm EDT.

The June 30th webinar will feature an Update on Lung Cancer Screening with a Review of the Expanded USPSTF Lung Cancer Screening Recommendation – why was the USPSTF recommendation expanded? What do the new criteria mean for disparities, health equity, risk assessment, and reimbursement?
 
Gerard Silvestri, MD, MS, Medical University of South Carolina, and former President of CHEST, will provide an overview of what we have learned from the first million screens in the ACR Lung Cancer Screening Registry. He will be joined for a follow-up discussion by

• NLCRT Chair, Ella Kazerooni, MD, MS, University of Michigan;
• Thomas Houston, MD, American Academy of Family Physicians;
• Melinda Aldrich, PhD, MPH, Vanderbilt University, and a
• Patient advocate.

The rest of the series will run on the following dates, all Eastern time:

• Jul 28, 2021 at 12:00 PM
• Aug 25, 2021 at 12:00 PM
• Sep 29, 2021 at 12:00 PM
• Oct 6, 2021 at 12:00 PM
• Nov 3, 2021 at 12:00 PM
• Nov 17, 2021 at 12:00 PM

» register